Pacer Global Cash Cows Dividend ETF
GCOW
Chicago Board Options Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Pacer Global Cash Cows Dividend ETF (GCOW) is an exchange-traded fund that seeks to track the total return performance, before fees and expenses, of the Pacer Global Cash Cows Dividend Index, focusing on global large-cap value stocks selected through free cash flow yield and dividend yield screens; the index excludes financial companies (other than REITs) and those with negative free cash flow based on analyst consensus estimates, then weights the top 100 remaining companies by their trailing 12-month dividends. The fund offers exposure to high free cash flow generating companies positioned to sustain dividends, with key characteristics including a weighted average market cap of $120.3 billion, free cash flow yield of 6.39%, dividend yield of 4.87%, and P/E ratio of 13.60 as of September 30, 2025; top sectors encompass health care (23.84%), energy (19.62%), and consumer staples (15.48%), while leading holdings feature AbbVie Inc. (2.32%), Johnson & Johnson (2.27%), and BP PLC (2.23%). GCOW provides investors with potential long-term capital appreciation, reduced volatility relative to broader markets, and income through dividends from developed market large-caps across regions such as the United States (33.64%), United Kingdom (14.45%), France (10.79%), and Japan (9.68%). Launched on February 22, 2016 and listed on Cboe, the fund is issued by Pacer ETFs, headquartered in Malvern, Pennsylvania, with total expenses of 0.60% and assets under management exceeding $2.3 billion. Recent developments include sustained quarterly dividend distributions, such as $0.0641, $0.3165, and $0.3455 per share declared in 2025, alongside positive analyst upgrades citing strong momentum, attractive valuations, and nearly three times the S&P 500 yield with anticipated 2025 alpha potential.